Navigation Links
Cholesterol Drugs May Raise Post-Op Delirium Risk
Date:9/22/2008

Patients on statin medications 30% more likely to experience trouble, study finds

MONDAY, Sept. 22 (HealthDay News) -- People who are taking cholesterol-lowering statin drugs -- which include Crestor, Lipitor, Pravachol and Zocor -- are more likely to suffer delirium after surgery, a Canadian study indicates.

Delirium is a common, and commonly neglected, experience for older people after any sort of surgery, according to study lead author Dr. Donald A. Redelmeier, professor of medicine at the University of Toronto.

"It's quite striking how some people are unable to recognize family members and don't know where they are," Redelmeier said. "It is sometimes prolonged and severe."

His team published its findings in the Sept. 23 issue of the Canadian Medical Association Journal.

The study included more than 284,000 people, 65 years of age and older, who had surgery in Ontario hospitals. The researchers reported that the incidence of delirium was 1 out of every 90 patients, but it was 30 percent more likely to occur in those taking statins before surgery.

These statistics are almost certainly too low, however, because "there is no question that delirium is often overlooked by the surgeon or family members or even the patient himself," Redelmeier said.

His estimate is that delirium occurs after about 10 percent of all surgical procedures, and that the incidence is 13 percent among people taking statins.

Redelmeier said he looked for a possible link between statins and post-op delirium, because "all clinical trials of statins focus on otherwise healthy outpatients under normal circumstances. Whereas, from my work in hospitals, I have found that medications that are safe under normal circumstances might not be safe at the time of surgery." Blood-thinning medications such as Coumadin, as well as sleeping pills, are other examples of drugs that raise delirium risks, he said.

Statins might increase the risk of delirium by shunting blood away from the brain to the heart, the report proposed. "It is plausible, but there are no biological data to support it," said one expert, Dr. Edward R. Marcantonio, associate professor of medicine at Harvard Medical School and the author of an accompanying editorial.

Marcantonio was also cautious about stopping statin therapy before surgery. "Before making a change in clinical management, I usually like to see stronger evidence in doing so," he said.

Marcantonio cited other factors that argued against stopping statins. "We certainly don't know the effect of taking patients off these drugs on outcomes other than delirium, such as cardiovascular conditions," he said. "They may have cardiovascular benefits above and beyond their lipid-lowering effects."

And, Marcantonio said, "There is always the risk of the drug never getting restarted."

Redelmeier has no such doubts. An internist, he does not do surgery himself but is often called in for consultation by surgeons. "I take the position that a brief interruption, for one or two days prior to surgery, is extremely simple, and if desired, you could restart the statin right there in the recovery room after surgery, so you get protection without any interaction with anesthetics," he reasoned.

More study is needed to settle the issue, Marcantonio said, and such a study would use better tools than those in the new report. Delirium has been underreported in the past because of reliance on reviews of medical records "or even abstraction into databases," he said. "One of the real advances has been development of interview tools to enable assessment of delirium in a reliable way."

Marcantonio has done such studies himself. "It is an expanding area of research -- ongoing studies of delirium where data may be available to do this sort of evaluation," he said. "Certainly, such a study is doable, perhaps within a couple of years."

More information

For more on statins, head to the National Heart, Lung, and Blood Institute.



SOURCES: Donald A. Redelmeier, M.D., professor, medicine, University of Toronto, Ontario, Canada; Edward R. Marcantonio, M.D., associate professor, medicine, Harvard Medical School, Boston; Sept. 23, 2008, Canadian Medical Association Journal


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Discoverers of Small Regulatory RNAs and Cholesterol-Lowering Drugs to Receive Lasker Awards for Medical Research
2. September 2008 Mayo Clinic Womens HealthSource Highlights Normal Weight Obesity, Regular Exercise and Cholesterol
3. Cholesterol Awareness Month: Americans Urged to Seek Early Intervention
4. Lipid Association Responds to New Cholesterol Guidelines for Children
5. Fish oil and red yeast rice studied for lowering blood cholesterol
6. Pediatricians Recommend Cholesterol Drugs for Some Kids
7. Gene variants linked to metabolic syndrome and HDL cholesterol levels
8. Nutrition 21 Launches Iceland Health(R) Cholesterol Health and Iceland Health(R) Joint Relief Plus SLEEP Support
9. Blood cholesterol levels predict risk of heart disease due to hormone therapy
10. Cholesterol Test Spots When HRT Raises Heart Risks
11. Oxidized LDL Cholesterol Linked to Metabolic Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cholesterol Drugs May Raise Post-Op Delirium Risk
(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids ... sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited ... all ages; it is a non-competitive, non-timed event, which is all about having fun ...
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... LA (PRWEB) , ... October 12, 2017 , ... Planet ... in the U.S., announced today its plans to open a flagship location in Covington, ... occupy the former Rooms To Go store next to Office Depot in the Holiday ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, ... post-acute health care, have expanded their existing home health joint venture through an ... has been operating a joint venture home health company with Asante, delivering clinically ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: